Global Plasma Therapy Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Published : 30 Aug 2024
Report Type : Global

Share This On

Home > Reports > Biotechnology > Agriculture > Global Plasma Therapy Market – Size, Outlook, Trends and Forecast (2024 – 2032)
CHAPTER 1. INTRODUCTION

    1.1. Market Definition

    1.2. Executive Summary

    1.3. The Scope of the Study

CHAPTER 2. RESEARCH METHODOLOGY

    2.1. Secondary Research

    2.2. Primary Research

    2.3. Analytic Tools and Model

    2.4. Economic Indicator

            2.4.1 Base Year, Base Currency, Forecasting Period

    2.5. Expert Validation

    2.6. Study Timeline

CHAPTER 3. MARKET ANALYSIS

    3.1. Industry Value Chain Analysis

    3.2. Porter's Five Force Analysis

            3.2.1. Bargaining Power of Buyers

            3.2.2. Bargaining Power of Suppliers

            3.2.3. Threats of Substitutes

            3.2.4. Threats of New Entrants

            3.2.5. Degree of Competition

    3.3. PESTLE Analysis

            3.3.1. Political

            3.3.2. Economical

            3.3.3. Social

            3.3.4. Technological

            3.3.5. Legal

            3.3.6. Environmental

    3.4. SWOT Analysis

            3.4.1. Strengths

            3.4.2. Weakness

            3.4.3. Opportunities

            3.4.4. Threats

    3.5. Y-O-Y Analysis

CHAPTER 4. MARKET DYNAMICS

    4.1. Market Drivers

            4.1.1. Increase in the number of androgenic alopecia patients worldwide

            4.1.2. Growing use of platelet-rich plasma in various therapeutic areas

            4.1.3. Prevalence of arthritis

            4.1.4. Increase in the number of androgenic alopecia patients worldwide

    4.2. Market Restraints & Challenges

            4.2.1. Lack of reimbursement policies

            4.2.2. Varying prices of plasma therapy

            4.2.3. Developments in other fields of regenerative medicine

    4.3. Market Opportunities

            4.3.1.  Increase in the number of patients suffering from orthopaedic disorders and

androgenic alopecia

CHAPTER 5. GLOBAL PLASMA THERAPY MARKET – BY TYPE

    5.1. Pure PRP

    5.2. Leukocyte-Rich PRP

    5.3. Pure Platelet-Rich Fibrin

    5.4. Leukocyte-Rich Fibrin

CHAPTER 6. GLOBAL PLASMA THERAPY MARKET – BY SOURCE TYPE

    6.1. Autologous

    6.2. Allogenic

CHAPTER 7. GLOBAL PLASMA THERAPY MARKET – BY APPLICATION

    7.1. Orthopaedic

            7.1.1. Arthritis

            7.1.2. Chronic Tendinitis

            7.1.3. Bone Repair & Regeneration

    7.2. Dermatology

            7.2.1. Androgenic Alopecia

            7.2.2. Plastic Surgery

    7.3. Cardiac Muscle Injury

    7.4. Dental

    7.5. Nerve Injury

    7.6. Others

CHAPTER 8. GLOBAL PLASMA THERAPY MARKET – BY END USER

    8.1. Hospitals & Clinics

    8.2. Research Institutes

CHAPTER 9. GLOBAL PLASMA THERAPY MARKET - BY GEOGRAPHY

    9.1. Introduction

    9.2. North America

            9.2.1. U.S.

            9.2.2. Canada

            9.2.3. Mexico

            9.2.4. Costa Rica

    9.3. South America

            9.3.1. Brazil

            9.3.2. Argentina

            9.3.3. Chile

            9.3.4. Columbia

            9.3.5. Others

    9.4. Europe

            9.4.1. U.K.

            9.4.2. Germany

            9.4.3. France

            9.4.4. Italy

            9.4.5. Spain

            9.4.6. Russia

            9.4.7. Netherlands

            9.4.8. Switzerland

            9.4.9. Poland

            9.4.10. Others

    9.5. APAC

            9.5.1. China

            9.5.2. Japan

            9.5.3. India

            9.5.4. South Korea

            9.5.5. Australia & New Zealand

            9.5.6. Malaysia

            9.5.7. Singapore

            9.5.8. Others

    9.6. Middle East & Africa

            9.6.1. UAE

            9.6.2. Saudi Arabia

            9.6.3. Iran

            9.6.4. Iraq

            9.6.5. Qatar

            9.6.6. South Africa

            9.6.7. Algeria

            9.6.8. Morocco

            9.6.9. Nigeria

            9.6.10. Egypt

            9.6.11. Others

CHAPTER 10. GLOBAL PLASMA THERAPY MARKET - COMPANY PROFILES

    10.1. CSL Ltd.

    10.2. Grifols International S.A.

    10.3. Kedrion S.P.A.

    10.4. LFB SA

    10.5. Bio Product Laboratory Ltd. (BPL)

    10.6. China Biologic Products, Inc.

    10.7. Octapharma AG

    10.8. Biolife Plasma Services

    10.9. Cambryn Biologics LLC

    10.10. Biotest

    10.11. Cambryn Biologics LLC

    10.12. Pluristem Therapeutics

    10.13. Cellular Biomedicine Group

    10.14. Caladrius Biosciences

CHAPTER 11. GLOBAL PLASMA THERAPY MARKET - COMPETITIVE

LANDSCAPE

    11.1. Market Share Analysis

    11.2. Strategies adopted by top companies

    11.3. Mergers, Acquisitions, Collaborations & Agreements

CHAPTER 12. MARKET INSIGHTS

    12.1. Industry Experts Insights

    12.2. Analysts Opinions

    12.3. Investment Opportunities

CHAPTER 13. APPENDIX

    13.1. List of Tables

    13.2. List of Figures

Other Reports

Global Sesame Seeds Market – Size, Outlook, Trends and...

Starting from $2700

Global Meat Ingredients Market – Growth, Trends And...

Starting from $2700

Unmanned Aerial Vehicle Drones Market – Size, Outlook,...

Starting from $2700

Stay in the loop

Keep up-to-date with our weekly newsletter, Media Pulse.

Data-driven market insights & solutions

Follow Us On

We Accept

Our Office

30 N Gould St Ste N Sheridan,
WY 82801

© 2025 - Envision Intelligence | All Rights Reserved.
Designed by Webixion